External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home JSH 2025
Roche and Genentech at

JSH 2025

October 10 - October 12
Kobe, Japan / Virtual (Hybrid)
jshem.or.jp
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:30 AM
Duration 60mins Kobe, Japan
2-year efficacy and safety in patients with paroxysmal nocturnal hemoglobinuria (PNH) who self-administered crovalimab▼ in the Phase III randomized COMMODORE 2 trial
Naoshi Obara, Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chai-Adisaksopha, Teresita E. Dumagay, Roberta Demichelis Gómez, Martin Höglund, Richard J. Kelly, Je-Hwan Lee, Jun-ichi Nishimura, Antonio Risitano, Anna Gaya, Anita Appius, Hannah Staunton, Sasha Sreckovic, Sammy Chebon, Simon Buatois, Bing Han
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.